24th Nov 2014 15:22
SHIRE PLC - Blocklisting - Interim ReviewSHIRE PLC - Blocklisting - Interim Review
PR Newswire
London, November 24
BLOCK LISTING SIX MONTHLY RETURN November 24, 2014 - Shire plc (LSE: SHP, NASDAQ: SHPG) Name of applicant: Shire plc Name of scheme: 2000 Executive Share Option Scheme Period of return: From: May 23, 2014 To: November 22, 2014 Balance of unallotted securities under 3,406,623scheme(s) from previous return: Plus: The amount by which the block Nilscheme(s) has been increased since thedate of the last return (if anyincrease has been applied for): Less: Number of securities issued/ Nilallotted under scheme(s) during period(see LR3.5.7G): Equals: Balance under scheme(s) not 3,406,623yet issued/allotted at end of period: Name of applicant: Shire plc Name of scheme: Shire Sharesave Scheme Period of return: From: May 23, 2014 To: November 22, 2014 Balance of unallotted securities under 210,392scheme(s) from previous return: Plus: The amount by which the block Nilscheme(s) has been increased since thedate of the last return (if anyincrease has been applied for): Less: Number of securities issued/ 2,634allotted under scheme(s) during period(see LR3.5.7G): Equals: Balance under scheme(s) not 207,758yet issued/allotted at end of period: Name of applicant: Shire plc Name of scheme: Portfolio Share Plan Period of return: From: May 23, 2014 To: November 22, 2014 Balance of unallotted securities under 1,594,259scheme(s) from previous return: Plus: The amount by which the block Nilscheme(s) has been increased since thedate of the last return (if anyincrease has been applied for): Less: Number of securities issued/ 456,045allotted under scheme(s) during period(see LR3.5.7G): Equals: Balance under scheme(s) not 1,138,214yet issued/allotted at end of period: Name of applicant: Shire plc Name of scheme: Employee Stock Purchase Plan Period of return: From: May 23, 2014 To: November 22, 2014 Balance of unallotted securities under 422,301scheme(s) from previous return: Plus: The amount by which the block 500,000scheme(s) has been increased since thedate of the last return (if anyincrease has been applied for): Less: Number of securities issued/ 397,591allotted under scheme(s) during period(see LR3.5.7G): Equals: Balance under scheme(s) not 524,710yet issued/allotted at end of period: Name of contact: Tony Guthrie, Deputy Company Secretary Address of contact: Hampshire International Business Park Basingstoke, Hampshire, RG24 8EP Telephone number of contact: 01256 894746 For further information please contact: Investor Relations Jeff Poulton [email protected] +1 781 482 0945 Sarah Elton-Farr [email protected] +44 1256 894157 NOTES TO EDITORS Shire enables people with life-altering conditions to lead better lives. Our strategy is to focus on developing and marketing innovative specialtymedicines to meet significant unmet patient needs. We focus on providing treatments in Neuroscience, Rare Diseases,Gastrointestinal, and Internal Medicine and we are developing treatments forsymptomatic conditions treated by specialist physicians in other targetedtherapeutic areas, such as Ophthalmology. www.shire.com Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX Press Release www.shire.com
Related Shares:
Shire